Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Why Penumbra Stock Is Popping Today

By Keith Speights - Oct 29, 2020 at 12:45PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The healthcare company posted better-than-expected Q3 results.

What happened

Shares of Penumbra ( PEN 4.58% ) were popping on Thursday, with the stock up 10.6% as of 12:15 p.m. EDT. The medical device maker announced better-than-expected third-quarter results after the market closed on Wednesday.

So what

Penumbra reported Q3 revenue of $151.1 million, up 8.3% year over year. This result topped the average analysts' estimate of $149.4 million.

Q3 written on a note attached to a clipboard with charts next to the clipboard

Image source: Getty Images.

The company posted a net loss in the third quarter of $8.8 million, or $0.24 per share, based on generally accepted accounting principles (GAAP). This loss was a steep drop from Penumbra's earnings of $0.32 per share in the prior-year period. However, the main culprit behind this loss was a one-time cost of $20.6 million related to the company's launch of its Lightning aspiration catheter. Without this expense, Penumbra would have been profitable in Q3.

Investors shouldn't make too much out of one quarterly update. However, Penumbra does appear to be on track to deliver stronger growth in the future.

Now what

The biggest wild card for the healthcare stock over the near term is the COVID-19 pandemic. Penumbra noted that it has "continued to see some positive trends in certain areas of our business beginning in May." However, the company also anticipates that the pandemic could cause some disruption with its revenue.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Penumbra, Inc. Stock Quote
Penumbra, Inc.
$248.99 (4.58%) $10.91

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/07/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.